Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 6816 (MIR6816, hsa-mir-6816) appears to be a putative or uncharacterized human microRNA, for which there is currently no substantial or validated experimental information available in major genomic or bibliographic databases. MicroRNAs are small, non-coding RNAs extensively involved in post-transcriptional gene regulation, typically by binding to complementary sequences on target mRNAs to repress translation or induce degradation[1][2][3][4]. However, no sequence, annotation, target, or disease association is documented for MIR6816. Its mention may arise from computational predictions, database artifact, or mistaken transcription of another microRNA ID. As of September 2025, it is not possible to ascribe specific biological or clinical relevance to this entry.
Not applicable for MIR6816. Generally, microRNAs act via incorporation into the RNA-induced silencing complex (RISC), which guides Ago2-mediated mRNA repression[1][3]. But no MoA is specified for MIR6816.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 6816 (MIR6816).